Results 121 to 130 of about 17,623 (143)

TDM-guided meropenem/vaborbactam-based therapy for successful treatment of intra-abdominal and bloodstream infection caused by KPC-producing ceftazidime/avibactam-resistant Klebsiella pneumoniae in a paediatric liver transplant recipient. [PDF]

J Antimicrob Chemother
Mulé G, Coniglione G, Gatti M, Cona A, Di Martino G, Ranucci G, de Ville de Goyet J, Pea F, Mularoni A.   +8 more
europepmc   +1 more source

Comparative Outcomes of Meropenem-Vaborbactam vs. Ceftazidime-Avibactam Among Adults Hospitalized with an Infectious Syndrome in the US, 2019-2021. [PDF]

Antibiotics (Basel)
Zilberberg MD, Nathanson BH, Redell MA, Sulham K, Shorr AF.   +4 more
europepmc   +1 more source

Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipients. [PDF]

J Antimicrob Chemother
Gatti M, Rinaldi M, Laici C, Ambretti S, Siniscalchi A, Viale P, Pea F.   +6 more
europepmc   +1 more source

Effect of Ceftaroline, Ceftazidime/Avibactam, Ceftolozane/Tazobactam, and Meropenem/Vaborbactam on Establishment of Colonization by Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice. [PDF]

Pathog Immun
Hausman BS, Memic S, Cadnum JL, Zink EG, Wilson BM, Donskey CJ.   +5 more
europepmc   +1 more source

Colistin, Meropenem-Vaborbactam, Imipenem-Relebactam, and Eravacycline Testing in Carbapenem-Resistant Gram-Negative Rods: A Comparative Evaluation of Broth Microdilution, Gradient Test, and VITEK 2. [PDF]

Antibiotics (Basel)
Forstner P, Fuchs L, Luxner J, Grisold A, Steinmetz I, Dichtl K.   +5 more
europepmc   +1 more source

First case report of a vertebral osteomyelitis caused by carbapenem-resistant Enterobacter cloacae treated with imipenem/cilastatin/relebactam prolonged infusion then meropenem/vaborbactam in continuous infusion. [PDF]

Front Pharmacol
Laffont-Lozes P, Naciri T, Pantel A, Martin A, Pruvot-Occean AS, Haignere V, Loubet P, Sotto A, Larcher R.   +8 more
europepmc   +1 more source

Systematic Review and Meta-Analysis of Clinical Efficacy and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections. [PDF]

Int J Mol Sci
Bucataru A, Turcu-Stiolica A, Calina D, Balasoiu AT, Zlatian OM, Osman A, Balasoiu M, Ghenea AE.   +7 more
europepmc   +1 more source

Genomic and molecular characterisation of a Klebsiella pneumoniae clinical isolate resistant to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam

Wan Y, Wong JLC, Sanchez-Garrido J, Low WW, Turton JF, Morecchiato F, Baccani I, Dodgson K, Rossolini GM, Woodford N, Frankel G, Jauneikaite E, Meunier D, Hopkins KL.   +13 more
europepmc   +1 more source